Targeting CD161 inhibitory receptors enhances NK cell-mediated changes in synovial fibroblast function in rheumatoid arthritis
CD161 is a potential biomarker for RA. Targeted inhibition of CD161 in NK cells alleviates synovial inflammation in RA, highlighting its therapeutic potential.
Authors
- Tao You (ORCID: https://orcid.org/0000-0002-1338-6630)
- Jia‐Le Song (ORCID: https://orcid.org/0000-0001-6269-5846)
- Guangxue Gu
- Jian Zhou (ORCID: https://orcid.org/0000-0002-7650-7540)
- Hongwei Yu (ORCID: https://orcid.org/0000-0002-5607-0628)
- Junqin Lu
- Wei Zhou (ORCID: https://orcid.org/0000-0003-3742-2592)
- Song Fu (ORCID: https://orcid.org/0000-0003-2052-7435)
- Haoyu Zhao (ORCID: https://orcid.org/0000-0002-0541-8495)
Institutions
- University of Science and Technology of China (CN)
- Anhui Medical University (CN)
- The First People’s Hospital of Lianyungang (CN)
- 181st Hospital of Chinese People's Liberation Army (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1016/j.intimp.2025.115528
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00